Cargando…

Vascular comorbidity is associated with decreased cognitive functioning in inflammatory bowel disease

Reports of cognitive impairment in inflammatory bowel disease (IBD) have been mixed. IBD and cardiovascular disease are often co-morbid, yet it remains unknown whether vascular comorbidity confers a risk for decreased cognitive functioning, as observed in other populations. Participants with IBD wer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Patel, Ronak, Marrie, Ruth Ann, Bernstein, Charles N., Bolton, James M., Graff, Lesley A., Marriott, James J., Figley, Chase R., Kornelsen, Jennifer, Mazerolle, Erin L., Uddin, Md Nasir, Fisk, John D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10017678/ https://www.ncbi.nlm.nih.gov/pubmed/36922532 http://dx.doi.org/10.1038/s41598-023-31160-3

Ejemplares similares

Effects of Vascular Comorbidity on Cognition in Multiple Sclerosis Are Partially Mediated by Changes in Brain Structure
por: Marrie, Ruth Ann, et al.
Publicado: (2022)

Differences in resting state functional connectivity relative to multiple sclerosis and impaired information processing speed
por: Carter, Sean L., et al.
Publicado: (2023)

The comorbidity and cognition in multiple sclerosis (CCOMS) neuroimaging protocol: Study rationale, MRI acquisition, and minimal image processing pipelines
por: Uddin, Md Nasir, et al.
Publicado: (2022)

Performance of Regression-Based Norms for Cognitive Functioning of Persons With Multiple Sclerosis in an Independent Sample
por: Marrie, Ruth Ann, et al.
Publicado: (2021)

Anxiety and depression affect performance on the symbol digit modalities test over time in MS and other immune disorders
por: Marrie, Ruth Ann, et al.
Publicado: (2020)

Well-being and flourishing mental health in adults with inflammatory bowel disease, multiple sclerosis and rheumatoid arthritis in Manitoba, Canada: a cross-sectional study
por: Almweisheer, Shaza, et al.
Publicado: (2023)

Potential Pitfalls of Using Fractional Anisotropy, Axial Diffusivity, and Radial Diffusivity as Biomarkers of Cerebral White Matter Microstructure
por: Figley, Chase R., et al.
Publicado: (2022)

Periventricular and juxtacortical characterization of UManitoba-JHU functionally defined human white matter atlas networks
por: Figley, Chase R., et al.
Publicado: (2023)

Neuropsychological and Structural Neuroimaging Outcomes in LGI1-Limbic Encephalitis: A Case Study
por: Joshi, Jarod, et al.
Publicado: (2022)

Prevalence and Risk Factors of Substance Use Disorder in Inflammatory Bowel Disease
por: Carney, Heather, et al.
Publicado: (2020)

Pain and participation in social activities in people with relapsing remitting and progressive multiple sclerosis
por: Jain, Dhruv, et al.
Publicado: (2023)

Within-person fluctuations over three years in depression, anxiety, fatigue, and health-related quality of life in multiple sclerosis
por: Marrie, Ruth Ann, et al.
Publicado: (2023)

Effects of Psychiatric Comorbidity in Immune-Mediated Inflammatory Disease: Protocol for a Prospective Study
por: Marrie, Ruth Ann, et al.
Publicado: (2018)

Incidence of Adverse Psychiatric Events During Treatment of Inflammatory Bowel Disease With Biologic Therapies: A Systematic Review
por: Jain, Avni, et al.
Publicado: (2019)

Effect of comorbid mood and anxiety disorders on breast and cervical cancer screening in immune-mediated inflammatory disease
por: Marrie, Ruth Ann, et al.
Publicado: (2021)

Impact of Psychiatric Comorbidity on Health Care Use in Rheumatoid Arthritis: A Population‐Based Study
por: Hitchon, Carol A., et al.
Publicado: (2020)

Effect of comorbidity on mortality in multiple sclerosis
por: Marrie, Ruth Ann, et al.
Publicado: (2015)

Comparisons between multi-component myelin water fraction, T1w/T2w ratio, and diffusion tensor imaging measures in healthy human brain structures
por: Uddin, Md. Nasir, et al.
Publicado: (2019)

Validity and Reliability of Screening Measures for Depression and Anxiety Disorders in Rheumatoid Arthritis
por: Hitchon, Carol A., et al.
Publicado: (2020)

Differing trends in the incidence of vascular comorbidity in MS and the general population
por: Marrie, Ruth Ann, et al.
Publicado: (2016)

Uptake of influenza vaccination among persons with inflammatory bowel disease, multiple sclerosis or rheumatoid arthritis: a population-based matched cohort study
por: Marrie, Ruth Ann, et al.
Publicado: (2021)

Quantitative Ex Vivo MRI Changes due to Progressive Formalin Fixation in Whole Human Brain Specimens: Longitudinal Characterization of Diffusion, Relaxometry, and Myelin Water Fraction Measurements at 3T
por: Shatil, Anwar S., et al.
Publicado: (2018)

Switching to second line MS disease-modifying therapies is associated with decreased relapse rate
por: Marriott, James John, et al.
Publicado: (2023)

Systematic review of interventions for depression and anxiety in persons with inflammatory bowel disease
por: Fiest, Kirsten M., et al.
Publicado: (2016)

Depressive symptom trajectories and polygenic risk scores in individuals with an immune-mediated inflammatory disease
por: Kowalec, Kaarina, et al.
Publicado: (2022)

Probabilistic White Matter Atlases of Human Auditory, Basal Ganglia, Language, Precuneus, Sensorimotor, Visual and Visuospatial Networks
por: Figley, Teresa D., et al.
Publicado: (2017)

Polygenicity of Comorbid Depression in Multiple Sclerosis
por: Kowalec, Kaarina, et al.
Publicado: (2023)

Prevalence and Risk Factors of Substance Use Disorder in Rheumatoid Arthritis
por: Kowalec, Kaarina, et al.
Publicado: (2021)

Factors Associated With Social Participation in Persons Living With Inflammatory Bowel Disease
por: Su, Samuel, et al.
Publicado: (2021)

Effect of mood and anxiety disorders on health care utilization in multiple sclerosis
por: Marrie, Ruth Ann, et al.
Publicado: (2020)

Use of Benzodiazepines and Z-Drugs in Multiple Sclerosis
por: Marrie, Ruth Ann, et al.
Publicado: (2022)

Prescription opioid use in multiple sclerosis
por: Marrie, Ruth Ann, et al.
Publicado: (2023)

Etiology, effects and management of comorbidities in multiple sclerosis: recent advances
por: Marrie, Ruth Ann, et al.
Publicado: (2023)

Physical comorbidities increase the risk of psychiatric comorbidity in multiple sclerosis
por: Marrie, Ruth Ann, et al.
Publicado: (2016)

The Barancik lecture: Comorbidity in multiple sclerosis—Looking backward, looking forward
por: Marrie, Ruth Ann
Publicado: (2023)

Differences in the burden of psychiatric comorbidity in MS vs the general population
por: Marrie, Ruth Ann, et al.
Publicado: (2015)

Longitudinal changes in microstructural white matter metrics in Alzheimer's disease
por: Mayo, Chantel D., et al.
Publicado: (2016)

Resting State BOLD Variability in Alzheimer’s Disease: A Marker of Cognitive Decline or Cerebrovascular Status?
por: Scarapicchia, Vanessa, et al.
Publicado: (2018)

The association of fatigue, pain, depression and anxiety with work and activity impairment in immune mediated inflammatory diseases
por: Enns, Murray W., et al.
Publicado: (2018)

Development and Internal Validation of a Disability Algorithm for Multiple Sclerosis in Administrative Data
por: Marrie, Ruth Ann, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_to96cp163eu1nd081da45217qd